These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26024928)

  • 1. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment.
    Rolstad S; Jakobsson J; Sellgren C; Isgren A; Ekman CJ; Bjerke M; Blennow K; Zetterberg H; Pålsson E; Landén M
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1091-8. PubMed ID: 26024928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.
    Rolstad S; Jakobsson J; Sellgren C; Ekman CJ; Blennow K; Zetterberg H; Pålsson E; Landén M
    PLoS One; 2015; 10(5):e0127100. PubMed ID: 25954806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder.
    Jakobsson J; Bjerke M; Sahebi S; Isgren A; Ekman CJ; Sellgren C; Olsson B; Zetterberg H; Blennow K; Pålsson E; Landén M
    J Psychiatry Neurosci; 2015 Jul; 40(4):250-8. PubMed ID: 25768030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
    Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
    Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
    Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.
    Alcolea D; Vilaplana E; Pegueroles J; Montal V; Sánchez-Juan P; González-Suárez A; Pozueta A; Rodríguez-Rodríguez E; Bartrés-Faz D; Vidal-Piñeiro D; González-Ortiz S; Medrano S; Carmona-Iragui M; Sánchez-Saudinós M; Sala I; Anton-Aguirre S; Sampedro F; Morenas-Rodríguez E; Clarimón J; Blesa R; Lleó A; Fortea J
    Neurobiol Aging; 2015 Jun; 36(6):2018-23. PubMed ID: 25865441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes.
    Isgren A; Sellgren C; Ekman CJ; Holmén-Larsson J; Blennow K; Zetterberg H; Jakobsson J; Landén M
    Brain Behav Immun; 2017 Oct; 65():195-201. PubMed ID: 28483660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    Wennström M; Surova Y; Hall S; Nilsson C; Minthon L; Hansson O; Nielsen HM
    PLoS One; 2015; 10(8):e0135458. PubMed ID: 26270969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
    Antonell A; Mansilla A; Rami L; Lladó A; Iranzo A; Olives J; Balasa M; Sánchez-Valle R; Molinuevo JL
    J Alzheimers Dis; 2014; 42(3):901-8. PubMed ID: 25024322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
    Malmeström C; Axelsson M; Lycke J; Zetterberg H; Blennow K; Olsson B
    J Neuroimmunol; 2014 Apr; 269(1-2):87-9. PubMed ID: 24582001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder.
    Forcada I; Mur M; Mora E; Vieta E; Bartrés-Faz D; Portella MJ
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):214-22. PubMed ID: 25172270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
    Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
    Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High BDNF serum levels are associated to good cognitive functioning in bipolar disorder.
    Mora E; Portella MJ; Piñol-Ripoll G; López R; Cuadras D; Forcada I; Teres M; Vieta E; Mur M
    Eur Psychiatry; 2019 Aug; 60():97-107. PubMed ID: 30808582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological evidence of impaired cognitive empathy in euthymic bipolar disorder.
    Shamay-Tsoory S; Harari H; Szepsenwol O; Levkovitz Y
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):59-67. PubMed ID: 19359453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders.
    Johansson V; Jakobsson J; Fortgang RG; Zetterberg H; Blennow K; Cannon TD; Hultman CM; Wetterberg L; Landén M
    Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):391-402. PubMed ID: 28039552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential patterns of neuropsychological performance in the euthymic and depressive phases of bipolar disorders.
    Ha TH; Chang JS; Oh SH; Kim JS; Cho HS; Ha K
    Psychiatry Clin Neurosci; 2014 Jul; 68(7):515-23. PubMed ID: 24612064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of cognitive impairment in bipolar disorder.
    Torrent C; Martinez-Arán A; del Mar Bonnin C; Reinares M; Daban C; Solé B; Rosa AR; Tabarés-Seisdedos R; Popovic D; Salamero M; Vieta E
    J Clin Psychiatry; 2012 Jul; 73(7):e899-905. PubMed ID: 22901360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study.
    Mora E; Portella MJ; Forcada I; Vieta E; Mur M
    Psychol Med; 2013 Jun; 43(6):1187-96. PubMed ID: 22935452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social cognition and global functioning in bipolar disorder.
    Lahera G; Ruiz-Murugarren S; Iglesias P; Ruiz-Bennasar C; Herrería E; Montes JM; Fernández-Liria A
    J Nerv Ment Dis; 2012 Feb; 200(2):135-41. PubMed ID: 22297310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.